Clinical Trial: OBPM_PANDA2026: Pivotal Evaluation of the Performance and Safety of the Aktiia Periodic Awake Optical Blood Pressure Monitoring (OBPM) Device at Wrist Against Double Auscultation: a Multicenter Prospective Clinical Study

U.S., April 3 -- ClinicalTrials.gov registry received information related to the study (NCT07507903) titled 'OBPM_PANDA2026: Pivotal Evaluation of the Performance and Safety of the Aktiia Periodic Awake Optical Blood Pressure Monitoring (OBPM) Device at Wrist Against Double Auscultation: a Multicenter Prospective Clinical Study' on March 27.

Brief Summary: This study, with N = 85 participants minimum over 2 visits spread over 7 days, has been designed to assess the accuracy and precision of the Blood Pressure and pulse rate values as generated by Aktiia.product-G1-US for up to 7 days after initialization in a cohort of subjects representative of the US population.

For the study, subjects will be asked to assume various body positions whil...